Targeted therapies and adverse drug reactions in oncology: the role of clinical pharmacist in pharmacovigilance
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2210-7711
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Targeted therapies and adverse drug reactions in oncology: the role of clinical pharmacist in pharmacovigilance ; day:21 ; month:5 ; year:2018 ; pages:1-8
International journal of clinical pharmacy ; (21.5.2018), 1-8
- Creator
-
Fornasier, G.
- Contributor
-
Taborelli, M.
Francescon, S.
Polesel, J.
Aliberti, M.
Paoli, P. De
Baldo, P.
SpringerLink (Online service)
- DOI
-
10.1007/s11096-018-0653-5
- URN
-
urn:nbn:de:101:1-2018080119261209888064
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:20 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Fornasier, G.
- Taborelli, M.
- Francescon, S.
- Polesel, J.
- Aliberti, M.
- Paoli, P. De
- Baldo, P.
- SpringerLink (Online service)
Other Objects (12)
Pharmacovigilance in oncology
Biosimilar Oncology Drugs in Europe: Regulatory and Pharmacovigilance Considerations
Targeted Therapies in Pediatric Oncology
Assessment of pharmacovigilance activities among pharmacist interns in Nigeria: a cross-sectional study
Safety of Biological Therapies for Severe Asthma: An Analysis of Suspected Adverse Reactions Reported in the WHO Pharmacovigilance Database
Managing immune-related adverse events in oncology
Dental Adverse Effects of Anti-CD20 Therapies
Small Molecules Drive Big Improvements in Immuno‐Oncology Therapies
Pharmacovigilance program to monitor adverse reactions of recombinant streptokinase in acute myocardial infarction
Pharmacovigilance workflow in Europe and Italy and pharmacovigilance terminology
A real-world pharmacovigilance study of FDA adverse event reporting system events for Capmatinib
Adverse event profiles of selpercatinib: a real-world pharmacovigilance analysis based on FAERS database
Pharmacovigilance in oncology
Biosimilar Oncology Drugs in Europe: Regulatory and Pharmacovigilance Considerations
Targeted Therapies in Pediatric Oncology
Assessment of pharmacovigilance activities among pharmacist interns in Nigeria: a cross-sectional study
Safety of Biological Therapies for Severe Asthma: An Analysis of Suspected Adverse Reactions Reported in the WHO Pharmacovigilance Database
Managing immune-related adverse events in oncology
Dental Adverse Effects of Anti-CD20 Therapies
Small Molecules Drive Big Improvements in Immuno‐Oncology Therapies
Pharmacovigilance program to monitor adverse reactions of recombinant streptokinase in acute myocardial infarction
Pharmacovigilance workflow in Europe and Italy and pharmacovigilance terminology
A real-world pharmacovigilance study of FDA adverse event reporting system events for Capmatinib
Adverse event profiles of selpercatinib: a real-world pharmacovigilance analysis based on FAERS database
Pharmacovigilance in oncology
Biosimilar Oncology Drugs in Europe: Regulatory and Pharmacovigilance Considerations
Targeted Therapies in Pediatric Oncology
Assessment of pharmacovigilance activities among pharmacist interns in Nigeria: a cross-sectional study
Safety of Biological Therapies for Severe Asthma: An Analysis of Suspected Adverse Reactions Reported in the WHO Pharmacovigilance Database
Managing immune-related adverse events in oncology
Dental Adverse Effects of Anti-CD20 Therapies
Small Molecules Drive Big Improvements in Immuno‐Oncology Therapies
Pharmacovigilance program to monitor adverse reactions of recombinant streptokinase in acute myocardial infarction
Pharmacovigilance workflow in Europe and Italy and pharmacovigilance terminology
A real-world pharmacovigilance study of FDA adverse event reporting system events for Capmatinib